IASLC 40th Anniversary - Progress in Lung Cancer
Since the 1970s, the International Association for the Study of Lung Cancer (IASLC) has promoted research into all aspects of lung cancer and other thoracic malignancies, as well as encouraged worldwide cancer prevention efforts.
Under the leadership of the IASLC Board of Directors, IASLC experts have participated in a historical review and documentation of the seminal and influential research that has impacted the treatment and prevention of thoracic cancers worldwide for more than 40 years.
The vision and tireless efforts of our CEOs, including Paul Bunn, Jr, MD, and Fred R. Hirsch, MD, have driven the work involved in documenting this 40-year history of the progress in lung cancer alongside the continuing guidance and vision of the IASLC Board of Directors.
This work, Progress in Lung Cancer, marking the 40th anniversary of the IASLC, was made possible through the generous support of Eli Lilly, which is gratefully acknowledged.
Advancement of the understanding of thoracic cancers and their treatment as well as enhancement of the quality of cancer care is the mission of the IASLC.
The story of the progress made in research and care of lung cancer is a demonstration of this mission in action and reflects the dedication and commitment of lung cancer specialists worldwide over the past 40 years.